论文信息 - Eligible and not eligible studies in the recent meta-analysis about p53 polymorphism and breast cancer risk - 字舞流文

Eligible and not eligible studies in the recent meta-analysis about p53 polymorphism and breast cancer risk

T. Sergentanis | K. Economopoulos

[1] Meilin Wang,et al. P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case–control studies , 2010, Breast Cancer Research and Treatment.

[2] Alison M Dunning,et al. Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk , 2007, Breast Cancer Research.

[3] Alison M Dunning,et al. Association between Common Variation in 120 Candidate Genes and Breast Cancer Risk , 2007, PLoS genetics.

[4] N. S. Murthy,et al. Polymorphism of the p53 codon 72 arg/pro and the risk of HPV type 16/18-associated cervical and oral cancer in India , 2003, Molecular and Cellular Biochemistry.

[5] N. Dalay,et al. P53 codon 72 polymorphism in breast cancer. , 2003, Oncology reports.

[6] H. Johnsen,et al. p53 polymorphism and risk of cervical cancer , 1998, Nature.

[7] N. Dalay,et al. p53 genotypes and haplotypes associated with risk of breast cancer. , 2007, Cancer detection and prevention.